22 July 2015 in Angiogenesis
1 February 2017 in Autoimmunity Reviews
23 October 2012 in Nature Reviews Rheumatology
24 July 2019 in Cellular and Molecular Life Sciences
14 December 2015 in Arthritis & Rheumatology
Objective: Levels of Toll‐like receptor 7 (TLR‐7) are elevated in rheumatoid arthritis (RA), but the impact on RA is unknown because the endogenous ligand for TLR‐7 has not been identified. The aim of this study was to identify a TLR‐7 endogenous ligand and to determine its role in the pathogenesis of RA.Methods: The presence of an endogenous TLR‐7 ligand, microRNA let‐7b (miR‐let‐7b), was examined by real‐time polymerase chain reaction (PCR) analysis. Using RA knockdown cells, TLR‐7–knockout mice, or antagonist, the specificity of miR‐let‐7b as a potential ligand for TLR‐7 was tested. The mechanism by which ligation of miR‐let‐7b to TLR‐7 promotes disease was investigated in RA myeloid cells by real‐time PCR, enzyme‐linked immunosorbent assay, and fluorescence‐activated cell sorting. We also established the effect of ectopic miR‐let‐7b expression on arthritic joint inflammation.Results: We found that a TLR‐7 endogenous ligand resides mainly in RA synovial fluid macrophages. The GU‐rich domain in miR‐let‐7b was found to be essential for TLR‐7 ligation, since miR‐147, the positive control for GU, was able to stimulate TLR‐7+ myeloid cells, whereas miR‐124, the negative, non‐GU, control, was not. We demonstrated that miR‐let‐7b or exosomes containing miR‐let‐7b could transform the RA and/or mouse naive or antiinflammatory macrophages into inflammatory M1 macrophages via TLR‐7 ligation. Consistently, we showed that miR‐let‐7b provokes arthritis by remodeling naive myeloid cells into M1 macrophages via TLR‐7 ligation, since joint swelling and M1 macrophages are absent in TLR‐7–deficient mice.Conclusion: The results of this study underscore the importance of miR‐let‐7b ligation to TLR‐7 in the joint during the effector phase of RA.
15 May 2013 in The Journal of Immunology
Although the role of IL-7 and IL-7R has been implicated in the pathogenesis of rheumatoid arthritis (RA), the majority of the studies have focused on the effect of IL-7/IL-7R in T cell development and function. Our novel data, however, document that patients with RA and greater disease activity have higher levels of IL-7, IL-7R, and TNF-α in RA monocytes, suggesting a feedback regulation between IL-7/IL-7R and TNF-α cascades in myeloid cells that is linked to chronic disease progression. Investigations into the involved mechanism showed that IL-7 is a novel and potent chemoattractant that attracts IL-7R+ monocytes through activation of the PI3K/AKT1 and ERK pathways at similar concentrations of IL-7 detected in RA synovial fluid. To determine whether ligation of IL-7 to IL-7R is a potential target for RA treatment and to identify their mechanism of action, collagen-induced arthritis (CIA) was therapeutically treated with anti–IL-7 Ab or IgG control. Anti–IL-7 Ab treatment significantly reduces CIA monocyte recruitment and osteoclast differentiation as well as potent joint monocyte chemoattractants and bone erosion markers, suggesting that both direct and indirect pathways might contribute to the observed effect. We also demonstrate that reduction in joint MIP-2 levels is responsible for suppressed vascularization detected in mice treated with anti–IL-7 Ab compared with the control group. To our knowledge, we show for the first time that expression of IL-7/IL-7R in myeloid cells is strongly correlated with RA disease activity and that ligation of IL-7 to IL-7R contributes to monocyte homing, differentiation of osteoclasts, and vascularization in the CIA effector phase.